CM
BIOSU

Cohanzick Management’s BioPlus Acquisition Corp. Unit BIOSU Stock Holding History

Cohanzick Management’s Portfolio BIOSU Stock Details BIOSU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-20,000
Closed -$200K – 468
2022
Q1 		$200K Hold
20,000
– – 0.05% 206
2021
Q4 		$200K Buy
+20,000
New +$200K 0.04% 202

Other funds holding BIOSU

Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
ACM
Atalaya Capital Management New York $45M AUM 3.02% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
SFM
Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
FLC
Fifth Lane Capital Austin, Texas $1.63M AUM 7.3% 1-Year Est. Return

Cohanzick Management's BIOSU Position: Q2 2022 in Review

Cohanzick Management sold out of BioPlus Acquisition Corp. Unit (BIOSU) in Q2 2022, closing a stake of 20,000 shares — an estimated $200K sold.

Cohanzick Management first reported a position in BIOSU in Q4 2021 and held it in 2 quarters. The position peaked at $200K in Q1 2022. 24 funds tracked by Wall St. Rank hold BIOSU as of Q2 2022.

  • Cohanzick Management reported no remaining BioPlus Acquisition Corp. Unit position as of Q2 2022 after selling out during the quarter.
  • Cohanzick Management sold 20,000 BioPlus Acquisition Corp. Unit shares in Q2 2022, an estimated $200K.
  • Cohanzick Management first reported a position in BioPlus Acquisition Corp. Unit in Q4 2021 and held it in 2 quarters.
  • Cohanzick Management's BioPlus Acquisition Corp. Unit position peaked at $200K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Unit as of Q2 2022.

Based on Cohanzick Management's 13F filing for Q2 2022, filed 12 Aug 2022.